U
RNVA

UBS’s Rennova Health, Inc. RNVA Stock Holding History

UBS’s Portfolio RNVA Stock Details RNVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$4K Buy
+1
New +$6.8K ﹤0.01% 9700
2014
Q2 		– Sell
-1
Closed -$12K – 11095
2014
Q1 		$12K Buy
+1
New +$15.8K ﹤0.01% 8734
2013
Q4 		– Hold
0
– – – 9926
2013
Q3 		– Sell
-1
Closed -$16.9K – 9478
2013
Q2 		$10K Buy
+1
New +$15.3K ﹤0.01% 8667

Other funds holding RNVA

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

UBS's RNVA Position: Q3 2014 in Review

UBS opened a new position in Rennova Health, Inc. (RNVA) in Q3 2014: 1 share worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #9700 among its holdings. This is a return to the name: UBS previously reported a position in RNVA as recently as Q1 2014.

UBS first reported a position in RNVA in Q2 2013 and has held it in 3 quarters since. The position peaked at $12K in Q1 2014. 5 funds tracked by Wall St. Rank hold RNVA as of Q3 2014.

  • UBS held 1 share of Rennova Health, Inc. worth $4K as of Q3 2014.
  • Rennova Health, Inc. was a new UBS position in Q3 2014.
  • Rennova Health, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9700 holding.
  • UBS first reported a position in Rennova Health, Inc. in Q2 2013 and has held it in 3 quarters since.
  • UBS's Rennova Health, Inc. position peaked at $12K in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Rennova Health, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.